Welcome to LookChem.com Sign In|Join Free
  • or
methyl 5-O-[3-O-(2,3,5-tri-O-acetyl-α-D-arabinofuranosyl)-2-O-benzoyl-5-O-tert-butyldiphenylsilyl-α-D-arabinofuranosyl]-2,3-di-O-benzoyl-α-D-arabinofuranoside is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

204918-67-2

Post Buying Request

204918-67-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

204918-67-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 204918-67-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,4,9,1 and 8 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 204918-67:
(8*2)+(7*0)+(6*4)+(5*9)+(4*1)+(3*8)+(2*6)+(1*7)=132
132 % 10 = 2
So 204918-67-2 is a valid CAS Registry Number.

204918-67-2Downstream Products

204918-67-2Relevant academic research and scientific papers

Arabinofuranosyl oligosaccharides from mycobacteria: Synthesis and effect of glycosylation on ring conformation and hydroxymethyl group rotamer populations

D'Souza, Francis W.,Ayers, Joseph D.,McCarren, Patrick R.,Lowary, Todd L.

, p. 1251 - 1260 (2007/10/03)

A series of αD-arabinofuranosyl oligosaccharides (2-8) that are fragments of the arabinan portions of two polysaccharides present in the cell wall of Mycobacterium tuberculosis have been synthesized. Preparation of the oligosaccharides involved the sequen

Synthetic arabinofuranosyl oligosaccharides as mycobacterial arabinosyltransferase substrates

Ayers, Joseph D.,Lowary, Todd L.,Morehouse, Caroline B.,Besra, Gurdyal S.

, p. 437 - 442 (2007/10/03)

A series of arabinofuranosyl oligosaccharides found as constituent parts of the polysaccharide portion of the cell wall of Mycobacterium tuberculosis have been chemically synthesized. Screening of these oligosaccharidss as substrates for arabinosyltransferases present in mycobacterial membrane preparations suggests that modified oligosaccharide analogs as small as disaccharides may be inhibitors of glycan biosynthesis. Such inhibitors would be of potential utility as lead compounds in the identification of new drugs for the treatment of mycobacterial infections.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 204918-67-2